Search Results - "Reyna, Denis E"
-
1
Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer
Published in Nature communications (07-03-2022)“…Deregulation of the BCL-2 family interaction network ensures cancer resistance to apoptosis and is a major challenge to current treatments. Cancer cells…”
Get full text
Journal Article -
2
Eltrombopag directly inhibits BAX and prevents cell death
Published in Nature communications (18-02-2021)“…The BCL-2 family protein BAX has essential activity in mitochondrial regulation of cell death. While BAX activity ensures tissue homeostasis, when dysregulated…”
Get full text
Journal Article -
3
An interconnected hierarchical model of cell death regulation by the BCL-2 family
Published in Nature cell biology (01-10-2015)“…Multidomain pro-apoptotic BAX and BAK, once activated, permeabilize mitochondria to trigger apoptosis, whereas anti-apoptotic BCL-2 members preserve…”
Get full text
Journal Article -
4
BH3-Triggered Structural Reorganization Drives the Activation of Proapoptotic BAX
Published in Molecular cell (12-11-2010)“…BAX is a proapoptotic BCL-2 family member that lies dormant in the cytosol until converted into a killer protein in response to cellular stress. Having…”
Get full text
Journal Article -
5
Direct and selective small-molecule activation of proapoptotic BAX
Published in Nature chemical biology (01-07-2012)“…A computational screen identifies a small-molecule activator of proapoptotic BAX that selectively binds to the BAX trigger site, inducing characteristic…”
Get full text
Journal Article -
6
An Autoinhibited Dimeric Form of BAX Regulates the BAX Activation Pathway
Published in Molecular cell (04-08-2016)“…Pro-apoptotic BAX is a cell fate regulator playing an important role in cellular homeostasis and pathological cell death. BAX is predominantly localized in the…”
Get full text
Journal Article -
7
Bax regulates primary necrosis through mitochondrial dynamics
Published in Proceedings of the National Academy of Sciences - PNAS (24-04-2012)“…The defining event in apoptosis is mitochondrial outer membrane permeabilization (MOMP), allowing apoptogen release. In contrast, the triggering event in…”
Get full text
Journal Article -
8
An Autoinhibited Dimeric Form of BAX Regulates the BAX Activation Pathway
Published in Molecular cell (20-10-2016)Get full text
Journal Article -
9
Small-molecule allosteric inhibitors of BAX
Published in Nature chemical biology (01-04-2019)“…BAX is a critical effector of the mitochondrial cell death pathway in response to a diverse range of stimuli in physiological and disease contexts. Upon…”
Get full text
Journal Article -
10
Progress in targeting the BCL-2 family of proteins
Published in Current opinion in chemical biology (01-08-2017)“…[Display omitted] •Selective BH3 mimetics for interrogating the BCL-2 protein family interactions and their development for cancer therapy.•Non-canonical…”
Get full text
Journal Article -
11
Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia
Published in Cancer cell (09-10-2017)“…The BCL-2 family protein BAX is a central mediator of apoptosis. Overexpression of anti-apoptotic BCL-2 proteins contributes to tumor development and…”
Get full text
Journal Article -
12
Self-regulation of BAX-induced cell death
Published in Oncotarget (11-10-2016)Get full text
Journal Article -
13
Pulling the BAX trigger for tumor cell death
Published in Oncotarget (02-02-2018)Get full text
Journal Article -
14
Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma
Published in The Laryngoscope (01-11-2020)“…Objectives To evaluate BCL‐2 family signaling molecules in head and neck squamous cell carcinoma (HNSCC) and examine the ability of therapeutic agents with…”
Get full text
Journal Article -
15
Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1
Published in Oncotarget (11-01-2019)“…Mechanisms of treatment resistance in head and neck squamous cell carcinoma (HNSCC) are not well characterized. In this study, HNSCC tumors from a cohort of…”
Get full text
Journal Article -
16
In Response to Regarding: Apoptosis Signaling Molecules as Treatment Targets in Head and Neck Squamous Carcinoma
Published in The Laryngoscope (01-08-2020)Get full text
Journal Article -
17
Abstract 1654: Chemical and structure-guided optimization of BAX trigger site activators for cancer therapy
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Cancer cells evade mitochondrial apoptosis most commonly by over-expressing anti-apoptotic BCL-2 proteins that suppress the activation of…”
Get full text
Journal Article -
18
Abstract 2455: BAM38 is a potent and selective pro-apoptotic BAX activator molecule that restores apoptosis in cancer cells
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Abstract Targeting key apoptosis regulators to overcome the apoptotic resistance of cancer cells is a highly attractive therapeutic strategy. The BCL-2 protein…”
Get full text
Journal Article -
19
Reply to “Regarding: Apoptosis Signaling Molecules as Treatment Targets in Head and Neck Squamous Carcinoma”
Published in The Laryngoscope (18-05-2020)Get full text
Journal Article -
20
BH3-Triggered Structural Reorganization Drives the Activation of Pro-apoptotic BAX
Published in Molecular cell (12-11-2010)“…BAX is a pro-apoptotic BCL-2 family member that lies dormant in the cytosol until converted into a killer protein in response to cellular stress. Having…”
Get full text
Journal Article